| Criteria for the diagnosis of corticobasal degeneration MJ Armstrong, I Litvan, AE Lang, TH Bak, KP Bhatia, B Borroni, AL Boxer, ... Neurology 80 (5), 496-503, 2013 | 1813 | 2013 |
| New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 1359 | 2022 |
| Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation H Lui, J Zhang, SR Makinson, MK Cahill, KW Kelley, HY Huang, Y Shang, ... Cell 165 (4), 921-935, 2016 | 700 | 2016 |
| Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy GU Höglinger, NM Melhem, DW Dickson, PMA Sleiman, LS Wang, L Klei, ... Nature genetics 43 (7), 699-705, 2011 | 651 | 2011 |
| Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis JD Rohrer, JM Nicholas, DM Cash, J Van Swieten, E Dopper, L Jiskoot, ... The Lancet Neurology 14 (3), 253-262, 2015 | 584 | 2015 |
| MCI conversion to dementia and the APOE genotype: A prediction study with FDG-PET L Mosconi, D Perani, S Sorbi, K Herholz, B Nacmias, V Holthoff, E Salmon, ... Neurology 63 (12), 2332-2340, 2004 | 447 | 2004 |
| Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference AL Young, RV Marinescu, NP Oxtoby, M Bocchetta, K Yong, NC Firth, ... Nature communications 9 (1), 4273, 2018 | 428 | 2018 |
| Frontotemporal dementia and its subtypes: a genome-wide association study R Ferrari, DG Hernandez, MA Nalls, JD Rohrer, A Ramasamy, JBJ Kwok, ... The Lancet Neurology 13 (7), 686-699, 2014 | 414 | 2014 |
| Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration JD Rohrer, T Lashley, JM Schott, JE Warren, S Mead, AM Isaacs, J Beck, ... Brain 134 (9), 2565-2581, 2011 | 409 | 2011 |
| Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease D Anchisi, B Borroni, M Franceschi, N Kerrouche, E Kalbe, ... Archives of neurology 62 (11), 1728-1733, 2005 | 382 | 2005 |
| Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status L Piccio, Y Deming, JL Del-Águila, L Ghezzi, DM Holtzman, AM Fagan, ... Acta neuropathologica 131, 925-933, 2016 | 352 | 2016 |
| A Pan‐European Study of the C9orf72 Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability, and Intermediate Repeats J van der Zee, I Gijselinck, L Dillen, T Van Langenhove, J Theuns, ... Human mutation 34 (2), 363-373, 2013 | 338 | 2013 |
| Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease B Borroni, C Bonvicini, A Alberici, E Buratti, C Agosti, S Archetti, A Papetti, ... Human mutation 30 (11), E974-E983, 2009 | 305 | 2009 |
| Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence V Garibotto, B Borroni, E Kalbe, K Herholz, E Salmon, V Holtoff, S Sorbi, ... Neurology 71 (17), 1342-1349, 2008 | 299 | 2008 |
| Neurofilament light chain: a biomarker for genetic frontotemporal dementia LH Meeter, EG Dopper, LC Jiskoot, R Sanchez‐Valle, C Graff, L Benussi, ... Annals of clinical and translational neurology 3 (8), 623-636, 2016 | 289 | 2016 |
| Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study KM Moore, J Nicholas, M Grossman, CT McMillan, DJ Irwin, L Massimo, ... The Lancet Neurology 19 (2), 145-156, 2020 | 286 | 2020 |
| Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy A Benussi, A Pilotto, E Premi, I Libri, M Giunta, C Agosti, A Alberici, ... Neurology 95 (7), e910-e920, 2020 | 281 | 2020 |
| Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration. M Cotelli, B Borroni, R Manenti, A Alberici, M Calabria, C Agosti, ... Neuropsychology 20 (5), 558, 2006 | 236 | 2006 |
| α-Secretase ADAM10 as Well as αAPPs Is Reduced in Platelets and CSF of Alzheimer Disease Patients F Colciaghi, B Borroni, L Pastorino, E Marcello, M Zimmermann, ... Molecular medicine 8, 67-74, 2002 | 233 | 2002 |
| Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ... Nature communications 12 (1), 3417, 2021 | 229 | 2021 |
